Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Filings indexed 572 across all filing types
Latest filing 2025-09-23 Regulatory Filings
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough - Attachment: Pham AK, Hiorth M, Rongved P. A novel and stable formulation of powdered high-ass
Regulatory Filings Classification · 100% confidence The document is a scientific research article titled 'A novel and stable formulation of powdered high-assay calcium hypochlorite as a solid precursor of the antimicrobial compound hypochlorous acid: a preformulation study'. It is published in the 'Journal of Drug Delivery Science and Technology' and includes sections such as 'Abstract', 'Introduction', and 'Materials and methods'. This is a peer-reviewed academic paper, not a corporate financial filing. Since the provided filing categories are strictly for corporate financial documents and there is no category for academic research, it falls under the 'Regulatory Filings' (RNS) category as the designated fallback for miscellaneous documents.
2025-09-23 English
SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough
Regulatory Filings Classification · 100% confidence The document is a short press release (2315 characters) announcing a scientific breakthrough regarding the stability of the company's core technology (HOCl) and its implications for an upcoming clinical trial. It does not contain full financial statements, audit reports, or regulatory filings, but rather serves as a corporate update on research and development progress. As it does not fit into specific categories like earnings releases or governance reports, it falls under the general regulatory announcement category.
2025-09-23 English
SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 - Attachment: SoftOx Solutions_Q2_Half Year Report_2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'SoftOx Solutions Group Q2 and Half Year Report H1 2025'. It contains comprehensive financial statements, including operating revenue, operating expenses, profit/loss, and cash flow data for the second quarter and the first half of 2025. It also includes detailed management commentary on clinical development strategy, funding activities, and operational outlook. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-09-17 English
SoftOx Solutions AS: Second Quarter/Half-Year Report 2025
Report Publication Announcement Classification · 100% confidence The document is extremely short (208 characters) and explicitly states 'Please find attached the Second Quarter/Half-Year Report 2025'. According to the 'Menu vs Meal' rule, an announcement stating that a report is attached or available is classified as a Report Publication Announcement (RPA), rather than the report itself.
2025-09-17 English
SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited
Capital/Financing Update Classification · 100% confidence The document announces that SoftOx Solutions AS is exercising a financing facility with Long State Investments Limited, which involves the issuance of up to 60 million shares. This is a direct update regarding the company's capital structure and financing activities, fitting the definition of a Capital/Financing Update (CAP).
2025-09-11 English
SoftOx Solutions AS: Presentation Deck and link to today's Investor Update - Attachment: 250908 Investor Update.pdf
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Investor Update' from SoftOx Solutions AS. It contains detailed information about the company's strategic shift, clinical focus, technology, market potential, and management team. It is clearly designed for investors to review the company's business strategy and pipeline, which fits the definition of an Investor Presentation.
2025-09-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.